News @ Xpedite
February 2021 - Launch of CE-IVD version of SwiftX™ Swabs
Xpedite Diagnostics is proud to announce that we have transformed our successful rapid nucleic acid extraction kit SwiftX™ Swabs into a CE-marked device under IVD Directive 98/79/EC.
November 2020 - Foundation of company and launch of first product
Xpedite Diagnostics GmbH was founded in November 2020. We started off immediately with launching our first product - SwiftX™ Swabs.
SwiftX™ Swabs is a simple yet powerful solution for nucleic acid extraction from swabs taken from throat, nose, buccal, skin and the like. It extracts DNA and RNA from viruses as well as host cells. The kit was validated for extraction of SARS-CoV-2 RNA from Covid19 patients. It is a cost-efficient alternative to classical NA extraction devices and is suited for high-throughput applications as well as for use at the point-of-care.